TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/27/24 20:00 | 6/26/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S | -72 | 4.75 | 0 | -15 | -5 | 264 | D | ||||||||||||||
6/3/24 20:00 | 5/31/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S | -45 | 6.09 | 0 | -7 | -3 | 279 | D | ||||||||||||||
1/5/24 16:04 | 1/4/24 | KALA | Kala Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S.d | -31 | 6.73 | 0 | -5 | -2 | 286 | D | ||||||||||||||
1/6/23 20:00 | 1/4/23 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S | -6 | 28.54 | 0 | 0 | 0 | 46 | D | ||||||||||||||
10/28/22 16:15 | 10/26/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S | -4 | 6.52 | 0 | -1 | -11 | 4 | D | ||||||||||||||
6/29/22 20:09 | 6/27/22 | KALA | Kala Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Iwicki Mark T | MA | DO | CEO | S | -3 | 0.3700 | 0 | -8 | -3 | 251 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |